Apellis Highlights Commercial Growth and Strategic Priorities at 43rd Annual J.P. Morgan ...
Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 ...